Tachyon Therapeutics
Latest round
- Seed
Last raised
- Sep 2022
Total raised
- $6M
Investors
- 3
About Tachyon Therapeutics
, develops therapeutics against new drug targets in cancer biology. In March 2023, Tachyon Therapeutics, Inc. Tachyon Therapeutics offers single-cell genomic analysis technology used for the treatment of various cancer types, such as colorectal, esophageal, breast, and lymphoma. The company’s therapeutic solution helps reduce tumor-initiating cancer stem cells responsible for relapses and metastases.
Who invested in Tachyon Therapeutics
3 investors across 1 round
See all investors in Tachyon Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 23, 2022
Amount
$6M
Investors
Questions about Tachyon Therapeutics
Who invested in Tachyon Therapeutics?
Tachyon Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tachyon Therapeutics raised?
Tachyon Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Tachyon Therapeutics last raise money?
Tachyon Therapeutics's most recent round on record is a Seed, in Sep 2022.
What does Tachyon Therapeutics do?
, develops therapeutics against new drug targets in cancer biology.
Where is Tachyon Therapeutics headquartered?
Tachyon Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like Tachyon Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Tachyon Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like Tachyon Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.